[A case of RAEB-t treated by G-CSF showing complete remission after MST-16 treatment for subsequent reversible leukemia]

Gan To Kagaku Ryoho. 1991 Sep;18(12):2155-8.
[Article in Japanese]

Abstract

A seventy-five-year-old female with general fatigue, high fever and anemia was admitted. Her chest X-ray film revealed pneumonia. She was diagnosed as RAEB-t with the normal karyotype by peripheral blood film and bone marrow aspiration; 125 micrograms/ml of G-CSF was administered s.c. daily in order to increase neutrophil count because of the prolongation of pneumonia. Her blast cells in both peripheral blood and bone marrow showed a remarkable increase by G-CSF. After the cessation of G-CSF administration, blast cells decreased rapidly, and neutrophil count in the peripheral blood increased. Her pneumonia was then cured. After 5 months of stable hematological state, 60% of her bone marrow cells became occupied by blast cells again. So 2 consecutive courses of 14 days p.o. administration of 1,200 mg MST-16/day were tried. Three months after the first MST-16 trial, her bone marrow showed complete remission (CR) which lasted about 4 months. But she died of sepsis after the first relapse. Her bone marrow in CR still revealed several features of dyspoiesis.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Acute Disease
  • Administration, Oral
  • Aged
  • Anemia, Refractory, with Excess of Blasts / pathology
  • Anemia, Refractory, with Excess of Blasts / therapy*
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Bone Marrow / pathology
  • Clone Cells
  • Female
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Humans
  • Leukemia / drug therapy*
  • Leukemia / pathology
  • Leukocyte Count
  • Neutrophils
  • Piperazines / administration & dosage
  • Piperazines / therapeutic use*
  • Remission Induction

Substances

  • Antineoplastic Agents
  • Piperazines
  • Granulocyte Colony-Stimulating Factor
  • sobuzoxane